Premium
Isolation of Bdellovibrio as Biological Therapeutic Agents Used For the Treatment of Aeromonas hydrophila Infection in Fish
Author(s) -
Chu W.H.,
Zhu W.
Publication year - 2010
Publication title -
zoonoses and public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.87
H-Index - 65
eISSN - 1863-2378
pISSN - 1863-1959
DOI - 10.1111/j.1863-2378.2008.01224.x
Subject(s) - aeromonas hydrophila , bdellovibrio , microbiology and biotechnology , biology , aeromonas , bacteria , lysis , staphylococcus aureus , bacterial disease , genetics
Summary Fourteen strains of Bdellovibrio ‐like organisms were isolated from cultured fish ponds using Aeromonas hydrophila J‐1 as host, one of them formed large plaques after 48 h of incubation at 28°C on a double layer plate, designated as Bdellovibrio C‐1. The Bdellovibrio was confirmed by electron microscopy and PCR amplification of Bdellovibrio ‐specific 16S rDNA. The optimum temperature for the growth of BdC‐1 was between 15–37°C and with optimal activity at temperatures of 25–30°C. The ability of BdC‐1 to lyse A. hydrophila was similar in the pH range of 6.5 to 8.5. It can lyse 23 Gram‐negative bacterial strains comprising three genera of fish pathogens and one strain of Escherichia coli but cannot lyse Gram‐positive bacteria such as Bacillus subtillis and Staphylococcus aureus . Immersion of fish in water containing different concentrations of BdC‐1 was used in protection against an experimental infection of A. hydrophila J‐1. Results show that the mortality of groups immersed with BdC‐1 was lower than the group without BdC‐1. These results suggest that it may be possible to use Bdellovibrio to control the disease caused by A. hydrophila .